DE69839395D1 - Aib1, ein steroidrezeptor co-aktivator - Google Patents

Aib1, ein steroidrezeptor co-aktivator

Info

Publication number
DE69839395D1
DE69839395D1 DE69839395T DE69839395T DE69839395D1 DE 69839395 D1 DE69839395 D1 DE 69839395D1 DE 69839395 T DE69839395 T DE 69839395T DE 69839395 T DE69839395 T DE 69839395T DE 69839395 D1 DE69839395 D1 DE 69839395D1
Authority
DE
Germany
Prior art keywords
activator
aib1
steroid receptor
steroid
steroid hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69839395T
Other languages
English (en)
Inventor
Paul Meltzer
Jeffrey M Trent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE69839395D1 publication Critical patent/DE69839395D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69839395T 1997-06-17 1998-06-17 Aib1, ein steroidrezeptor co-aktivator Expired - Lifetime DE69839395D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4972897P 1997-06-17 1997-06-17
PCT/US1998/012689 WO1998057982A2 (en) 1997-06-17 1998-06-17 Aib1, a steroid receptor co-activator

Publications (1)

Publication Number Publication Date
DE69839395D1 true DE69839395D1 (de) 2008-06-05

Family

ID=21961378

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69839395T Expired - Lifetime DE69839395D1 (de) 1997-06-17 1998-06-17 Aib1, ein steroidrezeptor co-aktivator

Country Status (8)

Country Link
US (3) US6562589B1 (de)
EP (1) EP0988317B1 (de)
JP (1) JP2002510208A (de)
AT (1) ATE393163T1 (de)
AU (1) AU732149B2 (de)
CA (1) CA2295332C (de)
DE (1) DE69839395D1 (de)
WO (1) WO1998057982A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999032621A2 (en) * 1997-12-22 1999-07-01 American Home Products Corporation Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof
US7132258B1 (en) 1998-02-04 2006-11-07 University Of Massachusetts Nucleic acid encoding vitamin D receptor related polypeptide
US6156571A (en) * 1999-11-15 2000-12-05 Isis Pharmaceuticals Inc. Antisense inhibition of SRC-3 expression
IT1318608B1 (it) * 2000-07-04 2003-08-27 Univ Degli Studi Milano Topo transgenico per lo screening e per studi di farmacodinamica efarmacocinetica di ligandi attivi sul recettore degli estrogeni e sui
WO2002010452A2 (en) * 2000-07-27 2002-02-07 University Of Rochester Methods and compositions for predicting prostate cancer
WO2003003904A2 (en) * 2001-07-05 2003-01-16 Georgetown University Medical Center Coactivators in the diagnosis and treatment of breast cancer
WO2003089904A2 (en) * 2002-04-17 2003-10-30 Baylor College Of Medicine Aib1 as a prognostic marker and predictor of resistance to encocrine therapy
IL149404A0 (en) * 2002-04-29 2002-11-10 Yissum Res Dev Co METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION
RU2405447C2 (ru) 2005-10-24 2010-12-10 Тайхо Фармасьютикал Ко., Лтд. СПОСОБ ПРОГНОЗИРОВАНИЯ ЭФФЕКТИВНОСТИ АГОНИСТА RAR-α
NZ575090A (en) * 2006-09-06 2012-02-24 Univ California Molecular diagnosis and classification of malignant melanoma using RGS1, ARPC2, FN1, SPP1 and WNT-2 polypeptide markers
US20240125768A1 (en) * 2021-02-10 2024-04-18 Etern Biopharma ( Shanghai)Co, Ltd. Methods for modulating a src-1 condensate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US5028525A (en) 1986-11-24 1991-07-02 Regents Of The University Of California Method of preparing and applying single stranded DNA probes to double stranded target DNAs in situ
WO1992005447A1 (en) 1990-09-21 1992-04-02 The Salk Institute For Biological Studies FUNCTIONAL ANTAGONISM BETWEEN PROTO-ONCOPROTEIN c-JUN AND HORMONE RECEPTORS
EP0643583B1 (de) 1992-05-06 2000-07-26 Immunomedics, Inc. Intraoperative, intravaskulare und endoskopische bestimmung und behandlung von verletzungen und tumoren
US5472842A (en) 1993-10-06 1995-12-05 The Regents Of The University Of California Detection of amplified or deleted chromosomal regions
US5506102A (en) 1993-10-28 1996-04-09 Ligand Pharmaceuticals Incorporated Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription
US5750336A (en) * 1994-02-10 1998-05-12 The Salk Institute For Biological Studies Assays for the identification of compounds which inhibit activation of cAMP and mitogen responsive genes
JP3517988B2 (ja) * 1994-09-21 2004-04-12 小野薬品工業株式会社 ヒトマッカード−ジョセフ病関連蛋白質、その蛋白質をコードするｃＤＮＡおよび遺伝子、そのＤＮＡまたは遺伝子を含むベクター、その発現ベクターで形質転換された宿主細胞、マッカード−ジョセフ病の診断方法および治療剤
AU725399B2 (en) * 1995-09-15 2000-10-12 Baylor College Of Medicine Steroid receptor coactivator compositions and methods of use
AU2332497A (en) 1996-03-19 1997-10-10 Salk Institute For Biological Studies, The (in vitro) methods for identifying modulators of members of the steroid/thyroid superfamily of receptors
AU4043897A (en) * 1996-07-23 1998-02-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The P300/cbp-associated transcriptional co-factor p/caf and uses thereof
US6812336B1 (en) * 1997-06-12 2004-11-02 The Regents Of The University Of California Transcription factor coactivator protein, p/CIP

Also Published As

Publication number Publication date
US20030153047A1 (en) 2003-08-14
CA2295332C (en) 2011-02-15
AU732149B2 (en) 2001-04-12
EP0988317B1 (de) 2008-04-23
US7232890B2 (en) 2007-06-19
WO1998057982A3 (en) 1999-03-18
US6562589B1 (en) 2003-05-13
CA2295332A1 (en) 1998-12-23
US20090023645A1 (en) 2009-01-22
EP0988317A2 (de) 2000-03-29
JP2002510208A (ja) 2002-04-02
ATE393163T1 (de) 2008-05-15
WO1998057982A2 (en) 1998-12-23
AU8150698A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
DE69839395D1 (de) Aib1, ein steroidrezeptor co-aktivator
EP0734264A4 (de) Verbindungen die spezifisch an kolorektale krebszellen binden und verfahren fuerihre herstellung
EP0932699A4 (de) Methode und reagenziensätze zum gewinnen und testen von brustflüssigkeitsproben um brustkrankheiten, einschliesslich krebs, nachzuweisen
YU83600A (sh) Adenozin a3 receptorski modulatori
BR9914116A (pt) Composições e métodos para imunoterapia especìfica de wt1
HUP0102744A2 (hu) Eljárás rákbetegségek korai diagnosztizálására
AU6473598A (en) Method for determining the presence of mutated brca protein
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
PT1015608E (pt) Metodos de ensaio de actividade de receptor e construcoes uteis nesses metodos
AU8072898A (en) Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
ATE197052T1 (de) Topiramate-immunoassay, sowie analoge und antikörper
Perosio et al. Expression of growth factors and growth factor receptors in soft tissue tumors. Implications for the autocrine hypothesis
ES2166822T3 (es) Procedimientos de seleccion de la enfermedad de crohn usando alelos de microsatelites de tnf.
ATE58437T1 (de) Nuklearbindungstest fuer steroidrezeptorsfunktion in krebsartigen zellen.
EP0373192A4 (en) Diagnostic genes for toxoplasmosis
DE69033128D1 (de) Für leberzellkarzinom spezifisches onkogen
SE9500030D0 (sv) Method of determining metastatic potential of tumor cells
DE60043942D1 (de) Fluoreszierende cobalamine und deren verwendung
EP0904283A4 (de) Menschliches netrin-1
DE69839846D1 (de) Bestimmung der vorhandenen mengen an cyclin-abhängr bei krebspatienten
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
Shackley X-Ray Fluorescence (XRF) Analysis of Obsidian Artifacts from the Spur Cross Ranch Site, AZ U: 1: 12 (ASU)
UA33566A (uk) Спосіб кількісного визначення ципрофлоксацину
ZA943783B (en) Method for examination of hormone-dependent tumors
EP1243653A3 (de) E25a Protein, Methoden zur Herstellung und Verwendung

Legal Events

Date Code Title Description
8332 No legal effect for de